Patents by Inventor Linda Jane Solomon

Linda Jane Solomon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9115182
    Abstract: Compositions and methods are provided using fusion peptides comprising at least one multi-functional solubility tag having an effective number of cross-linkable cysteines residues. The multi-functional peptidic solubility tags facilitate efficient fusion peptide production, easier downstream processing of the fusion peptide, and provide functional surface properties when coupled to a target material while the cross-linkable cysteines provide enhanced durability when binding the fusion peptide to a target material.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: August 25, 2015
    Assignee: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: Stephen R Fahnestock, Kari A Fosser, Tanja Maria Gruber, Pierre E Rouviere, Linda Jane Solomon
  • Patent number: 8815550
    Abstract: Disclosed herein are compositions and methods to target enzymatic peracid production to a target surface. The peracid benefit agent produced by the targeted perhydrolytic enzyme can be use for a variety of applications such as bleaching, whitening, disinfecting, destaining, deodorizing, and combinations thereof. Specifically, a fusion protein comprising a perhydrolytic enzyme and at least one peptidic component having affinity for a target surface (excluding body surfaces and oral care surfaces) is used in combination with a suitable substrate and a source of peroxygen to enzymatically produce a peracid on or near the surface of the target material. In a preferred aspect, the target surface is a cellulosic material.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: August 26, 2014
    Assignee: E I du Pont de Nemours and Company
    Inventors: Robert DiCosimo, Scott D Cunningham, Stephen R Fahnestock, Tanja Maria Gruber, Mark S Payne, Pierre E Rouviere, Linda Jane Solomon, Hong Wang
  • Publication number: 20140073029
    Abstract: Disclosed herein are compositions and methods to target enzymatic peracid production to a target surface. The peracid benefit agent produced by the targeted perhydrolytic enzyme can be use for a variety of applications such as bleaching, whitening, disinfecting, destaining, deodorizing, and combinations thereof. Specifically, a fusion protein comprising a perhydrolytic enzyme and at least one peptidic component having affinity for a target surface (excluding body surfaces and oral care surfaces) is used in combination with a suitable substrate and a source of peroxygen to enzymatically produce a peracid on or near the surface of the target material. In a preferred aspect, the target surface is a cellulosic material.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 13, 2014
    Applicant: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: ROBERT DICOSIMO, Scott D. Cunningham, Stephen R. Fahnestock, Tanja Maria Gruber, Mark S. Payne, Pierre E. Rouviere, Linda Jane Solomon, Hong Wang
  • Patent number: 8652455
    Abstract: Disclosed herein are compositions and methods to target enzymatic peracid production to a target surface. The peracid benefit agent produced by the targeted perhydrolytic enzyme can be use for a variety of applications such as bleaching, whitening, disinfecting, destaining, deodorizing, and combinations thereof. Specifically, a fusion protein comprising a perhydrolytic enzyme and at least one peptidic component having affinity for a target surface (excluding body surfaces and oral care surfaces) is used in combination with a suitable substrate and a source of peroxygen to enzymatically produce a peracid on or near the surface of the target material. In a preferred aspect, the target surface is a cellulosic material.
    Type: Grant
    Filed: December 19, 2011
    Date of Patent: February 18, 2014
    Assignee: E I du Pont de Nemours and Company
    Inventors: Robert DiCosimo, Scott D. Cunningham, Stephen R. Fahnestock, Tanja Maria Gruber, Mark S. Payne, Pierre E. Rouviere, Linda Jane Solomon, Hong Wang
  • Patent number: 8617843
    Abstract: The invention relates to the recombinant expression of a peptide of interest in the form of a fusion protein comprising a solubility tag. The fusion protein comprises at least two portions separated by a cleavable peptide sequence wherein one portion is devoid of cysteine residues and the second portion comprises an effective number of cross-linkable cysteine residues. After cell lysis and isolation of the fusion protein, the fusion protein is subsequently cleaved into a mixture of first and second portions. Oxidative cross-linking is used to selectively precipitate one of the two portions to facilitate simple and effective separation of the peptide of interest.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: December 31, 2013
    Assignee: E I du Pont de Nemours and Company
    Inventors: Albert W. Alsop, Qiong Cheng, Linda Jane Solomon, Stephen R. Fahnestock, Tanja Maria Gruber, Pierre E. Rouviere
  • Publication number: 20130157927
    Abstract: Compositions and methods are provided using fusion peptides comprising at least one multi-functional solubility tag having an effective number of cross-linkable cysteines residues. The multi-functional peptidic solubility tags facilitate efficient fusion peptide production, easier downstream processing of the fusion peptide, and provide functional surface properties when coupled to a target material while the cross-linkable cysteines provide enhanced durability when binding the fusion peptide to a target material.
    Type: Application
    Filed: February 20, 2013
    Publication date: June 20, 2013
    Inventors: STEPHEN R. FAHNESTOCK, Kari A. Fosser, Tanja Maria Gruber, Pierre E. Rouviere, Linda Jane Solomon
  • Publication number: 20120321581
    Abstract: Disclosed herein are compositions and methods to target enzymatic peracid production to a target surface. The peracid benefit agent produced by the targeted perhydrolytic enzyme can be use for a variety of applications such as bleaching, whitening, disinfecting, destaining, deodorizing, and combinations thereof. Specifically, a fusion protein comprising a perhydrolytic enzyme and at least one peptidic component having affinity for a target surface (excluding body surfaces and oral care surfaces) is used in combination with a suitable substrate and a source of peroxygen to enzymatically produce a peracid on or near the surface of the target material. In a preferred aspect, the target surface is a cellulosic material.
    Type: Application
    Filed: December 19, 2011
    Publication date: December 20, 2012
    Applicant: E.I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Robert DiCosimo, Scott D. Cunningham, Stephen R. Fahnestock, Tanja Maria Gruber, Mark S. Payne, Pierre E. Rouviere, Linda Jane Solomon, Hong Wang
  • Publication number: 20110183373
    Abstract: The invention relates to the recombinant expression of a peptide of interest in the form of a fusion protein comprising a solubility tag. The fusion protein comprises at least two portions separated by a cleavable peptide sequence wherein one portion is devoid of cysteine residues and the second portion comprises an effective number of cross-linkable cysteine residues. After cell lysis and isolation of the fusion protein, the fusion protein is subsequently cleaved into a mixture of first and second portions. Oxidative cross-linking is used to selectively precipitate one of the two portions to facilitate simple and effective separation of the peptide of interest.
    Type: Application
    Filed: April 6, 2011
    Publication date: July 28, 2011
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: ALBERT W. ALSOP, QIONG CHENG, LINDA JANE SOLOMON, STEPHEN R. FAHNESTOCK, TANJA MARIA GRUBER, PIERRE E. ROUVIERE
  • Patent number: 7951559
    Abstract: The invention relates to the recombinant expression of a peptide of interest in the form of a fusion protein comprising a solubility tag. The fusion protein comprises at least two portions separated by a cleavable peptide sequence wherein one portion is devoid of cysteine residues and the second portion comprises an effective number of cross-linkable cysteine residues. After cell lysis and isolation of the fusion protein, the fusion protein is subsequently cleaved into a mixture of first and second portions. Oxidative cross-linking is used to selectively precipitate one of the two portions to facilitate simple and effective separation of the peptide of interest.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: May 31, 2011
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Albert W. Alsop, Qiong Cheng, Linda Jane Solomon, Stephen R. Fahnestock, Tanja Maria Gruber, Pierre E. Rouviere